✦ LIBER ✦

A Phase II study on the safety and efficacy of a single dose of pegfilgrastim for mobilization and transplantation of autologous hematopoietic stem cells in pediatric oncohematology patients

✍ Scribed by Simone Cesaro; Andrea Giulio Zanazzo; Stefano Frenos; Roberto Luksch; Anna Pegoraro; Gloria Tridello; Sandro Dallorso

Book ID: 109146454
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 86 KB
Volume: 51
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2011.03157.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced dose of lenograstim is as effica

Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: A randomized study in patients undergoing autologous peripheral stem cell transplantation

✍ Selmin Ataergin; Fikret Arpaci; Mustafa Turan; Luis Solchaga; Turker Cetin; Must 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

High-dose chemotherapy and autologous he

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: Results of an open study to assess feasibility, safety, and efficacy

✍ Robert J. Verburg; Aike A. Kruize; Frank H. J. van den Hoogen; Willem E. Fibbe; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

A prospective, double-blind phase II stu

A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation

✍ Elad, S; Ackerstein, A; Bitan, M; Shapira, M Y; Resnick, I; Gesundheit, B; Cohen 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

Comparison of fixed dose pegfilgrastim a

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis

✍ Felicetto Ferrara; Tiziana Izzo; Clelia Criscuolo; Cira Riccardi; Assunta Viola; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract Different authors have explored the feasibility of autografting patients with multiple myeloma (MM) on an outpatient basis. Peg‐filgrastim (PEG), a long‐acting recombinant G‐CSF, has similar efficacy when compared to conventional G‐CSF for chemotherapy‐induced neutropenia, but little is

A phase II study of ondansetron as antie

A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation

✍ V. Barbounis; G. Koumakis; M. Vassilomanolakis; H. Hatzichristou; S. Tsousis; A. 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 651 KB

The field of high-dose chemotherapy with stem cell transplantation has been expanded recently as a treatment for solid tumors and hematological malignancies. Severe emesis remains one of the main extramedullary side-effects of high-dose regimens during the first week of treatment. Traditional antiem

A phase II trial evaluating the safety a

A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation

✍ Pecora, A L; Stiff, P; LeMaistre, C F; Bayer, R; Bachier, C; Goldberg, S L; Part 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 129 KB